# Basecare Medical Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/basecare-medical-corporation

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.basecare.cn
- Total disclosed funding: $21M
- Latest round: Series C (May 15, 2020)
- Investors on record: 5

## About

Based in Suzhou, China, and founded in 2010 Basecare Medical Corporation Limited provides medical tools for pre-implantation genetic screening. In February 2015, the company secured an undisclosed amount of series A funding co-led by Bio Venture and Oriza Holdings. In September 2017, it was followed by CNY 100 million of series B funding, and in May 2020, CNY 150 million from Bohua Asset Management and Ming Bioventures.

Basecare developed a number of medical tools in the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. In addition, it provides DNA sequencing solutions, including technology support, training, data analysis, and management services for medical institutions. 

The company generates revenue from the sale of its devices for embryonic pre-implantation genetic screening. For the last 9 months of 2020, Basecare Medical Corporation Limited has increased its revenue growth by 35.44% reaching CNY 15.61 million and reaching the highest profit margin of 48.2%.

The company’s future strategy includes putting 20% of its profits from product sales to commercialize PGT-A test kits. Additionally, In the Years 2022 to 2025, the company plans to commercialize as well the PGT-M kits, PGT-SR, CNV, and WES.

## Funding rounds

- Series C, May 15, 2020, $21M — Redpoint Ventures, Ming Bioventures, Broad Vision Funds
- Series A, Feb 10, 2015 — Oriza Holdings, YuanBio Venture

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Redpoint Ventures (https://capitalatlas.ai/funds/redpoint-ventures) — Series C
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series C
- Broad Vision Funds (https://capitalatlas.ai/funds/broad-vision-funds) — Series C